The potential impact on the health and well-being of individuals with brain injuries are numerous. These individuals might display a range of symptoms — such…
In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins…
In a National Science Foundation funded study, Kathleen Alexander, an associate professor of wildlife at Virginia Tech, found that climate drives a large part…
Multiple sclerosis (MS) is a disease for which no cure has yet been found. Its progression may be delayed thanks to new drugs, but the active ingredients in…
Maintaining adequate levels of vitamin D can help people breathe better and may even protect against tuberculosis (TB), according to a recent study accepted…
“We've essentially identified the molecular “key” that herpes viruses use to penetrate cell membranes and infect cells of the human body,” said Betsy Herold,…
The harm done by konzo – a disease overshadowed by the war and drought it tends to accompany – goes beyond its devastating physical effects to impair…
The study, published today in the journal Nature Neuroscience, also describes changes in the patterns of brain activity of adults in their seventies that help…
Despite this, the operation is not frequently performed, either in Sweden or elsewhere. Researchers at the Sahlgrenska Academy, University of Gothenburg,…
Extended cooling can prevent brain injuries, but this treatment is not always available in developing nations where advanced medical care is scarce. To address…
More than 50,000 stem cell transplants are performed each year worldwide. A research team led by Weill Cornell Medical College investigators may have solved a…
A growing body of research by multiple sclerosis (MS) investigators at the University at Buffalo and international partners is providing powerful new evidence…
A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of…
In a study published today in the journal Cellular and Molecular Life Sciences the researchers show that COPD patients who do not express Siglec-14, a…
Though it has anecdotally been successful, the evidence to support its efficaciousness is weak. Researchers at the Rothman Institute at Jefferson participated…
Javad Parvizi, MD, and colleagues at the Rothman Institute at Jefferson have worked for years to find a solution to this sometimes deadly infection. Their most…
Feedback
